Rongwu Xiang

Shenyang Pharmaceutical University — China

Computer Science · Physical Sciences

19h-index1.1kcitations59works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Computational Drug Discovery Methods(10), Metabolomics and Mass Spectrometry Studies(5), Bioinformatics and Genomic Networks(5), Neuroscience and Neuropharmacology Research(4), Drug Solubulity and Delivery Systems(4)

Publications59 total

A novel risk-scoring model for predicting cancer-specific mortality and instituting chemotherapy in elderly patients with esophageal cancer
Diseases of the Esophagus·2025
A New Bisamide from Piper longum and its Molecular Docking Study with Akt
Chemistry of Natural Compounds·2025
Explainable Artificial Intelligence in the Field of Drug Research
Drug Design Development and Therapy·2025· 12 citedOpen Access
Dynamic neural representations of scene beauty are relatively unaffected by stimulus timing and task
2025Open Access
A Directed Weighted Network-Based Method for Drug Combinations Identification Using Drug-Target and Inter-target Regulation
2025Open Access
Target rule exploration of drug combination based on directed weighted network
2024Open Access
Effects of chronic unpredictable mild stress on gut sensation and function in male mice
Stress·2024· 2 citedOpen Access
DrugSK: A Stacked Ensemble Learning Framework for Predicting Drug Combinations of Multiple Diseases
Journal of Chemical Information and Modeling·2024· 4 cited
Retraction Note: Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer
Functional & Integrative Genomics·2024· 1 citedOpen Access
Knowledge mapping of graph neural networks for drug discovery: a bibliometric and visualized analysis
Frontiers in Pharmacology·2024· 18 citedOpen Access
Factors associated with the onset and survival of subsequent primary breast cancer in female non‐metastatic breast cancer survivors
Precision Medical Sciences·2024Open Access
MSAmix-Net: Diabetic Retinopathy Classification
IEEE Access·2024· 6 citedOpen Access
Combining ResNet and RBF Networks to Enhance the Robustness of Diabetic Retinopathy Detection Against FGSM Attacks
2023
Research focus and thematic trends of transient receptor potential vanilloid member 1 research: a bibliometric analysis of the global publications (1990–2023)
Naunyn-Schmiedeberg s Archives of Pharmacology·2023· 1 cited
Butein, a potential drug for the treatment of bone cancer pain through bioinformatic and network pharmacology
Toxicology and Applied Pharmacology·2023· 9 citedOpen Access
Develop adult extrapolation to pediatrics and pediatric dose optimization based on the physiological pharmacokinetic model of azithromycin
Biopharmaceutics & Drug Disposition·2023· 4 citedOpen Access
RETRACTED ARTICLE: Ensemble learning-based gene signature and risk model for predicting prognosis of triple-negative breast cancer
Functional & Integrative Genomics·2023· 6 cited
Ionizable drug delivery systems for efficient and selective gene therapy
Military Medical Research·2023· 22 citedOpen Access
A bibliometric and visualized analysis of liver fibrosis from 2002 to 2022
Journal of Gastroenterology and Hepatology·2022· 11 cited
Butein, a potential drug for the treatment of Bone Cancer Pain through bioinformatic and network pharmacology
2022Open Access
page 1 of 3Next →

Frequent Co-authors

Fei Zhai(13), Jingyu Yang(10), Guixia Ling(8), Mingyi Zhao(6), Shubing Jia(6), Xiwei Jiang(6), Liang Fang(5), Chunfu Wu(4), Dongmei Cun(4), Luhua Liang(4), Ping Liu(3), Tingyan Song(3), Ruobing Han(3), Gang Chen(3), Yue‐Hu Pei(3), Peng Quan(3), Qianqian Zhao(3), Kai Ma(3), Yijia Xu(3), Hao Pan(2)